Logo image of NVNO

ENVVENO MEDICAL CORP (NVNO) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:NVNO - US29415J1060 - Common Stock

0.328 USD
+0.01 (+1.67%)
Last: 11/21/2025, 8:00:02 PM
0.3285 USD
+0 (+0.15%)
After Hours: 11/21/2025, 8:00:02 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to NVNO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 12.75. This target is 3787.2% above the current price.
NVNO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NVNO.
In the previous month the buy percentage consensus was at a similar level.
NVNO was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

NVNO Historical Analyst RatingsNVNO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -70 -63 -56 -49 -42 -35 -28 -21 -14 -7 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 0.3312.6312.7512.7513.13 - 3,749.09% 3,787.20% 3,787.20% 3,901.52%

Related screens

NVNO Current Analyst RatingNVNO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

ENVVENO MEDICAL CORP / NVNO FAQ

What do analysts expect the price target to be for ENVVENO MEDICAL CORP (NVNO)?

6 analysts have analysed NVNO and the average price target is 12.75 USD. This implies a price increase of 3787.2% is expected in the next year compared to the current price of 0.328.


What is the consensus rating for ENVVENO MEDICAL CORP (NVNO) stock?

The consensus rating for ENVVENO MEDICAL CORP (NVNO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.